NCT04459468Completed
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for Hepatocellular Carcinoma (HCC)
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
This study will enroll patients with hepatocellular carcinoma being planned for TACE or other standard of care treatment (such as denovo ablation or Y90) and obtain blood samples pre and post treatment procedure for biomarker identification using bead based X-aptamer library. No intervention is planned.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 17 (actual)
- First submitted
- 1 Jul 2020
- Start date
- 4 Nov 2022
- Primary completion date
- 23 Sept 2025
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT04459468
What you commit to
- Study type: Observational
- Participants enrolled: 17
- From 4 Nov 2022 to the primary completion date, 23 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects who have received chemotherapy, radiation or surgery for HCC.
Who the study is looking for
- Ability to understand and the willingness to sign a written informed consent.
- Male or female aged 18-70years.
- Diagnosed with primary or metastatic liver cancer.
- Scheduled to undergo Lipoidal TACE, denovo ablation, or Yttrium-90 (Y90) radioembolization as part of standard of care.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.